Pricing Log in Create free account

Bicara Therapeutics Inc. (BCAX) vs Alpha Tau Medical Ltd. (DRTS)

Bicara Therapeutics Inc. and Alpha Tau Medical Ltd. are both Biotechnology companies. Bicara Therapeutics Inc. and Alpha Tau Medical Ltd. are of similar size ($1.2B and $1.2B). Across the 9 metrics below, Alpha Tau Medical Ltd. leads on 5 and Bicara Therapeutics Inc. on 4.

Valuation

Metric BCAX DRTS Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 2.43 25.03 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (18.47%) (4.56%) (33.15%)
Free cash flow yield (11.87%) (3.55%) (25.50%)

Profitability

Metric BCAX DRTS Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (41.01%) 0.00% (56.36%)
Return on assets (38.38%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BCAX DRTS Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 37.78% (17.78%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BCAX DRTS Biotechnology median
Debt to equity 0.00 0.15 0.00
Current ratio 11.59 11.09 4.72
Net debt to EBITDA 2.67 1.63 0.96

Dividend

Metric BCAX DRTS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BCAX DRTS Biotechnology median
Market cap 1.17b 1.22b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack